Measured Wealth Private Client Group, LLC

Position in HLN — Haleon plc

CIK 1720235 PORTSMOUTH, NH

Back to HLN Full portfolio

Position in HLN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$18,632

-$1,357 QoQ

Shares Held

1,997

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#448

of 639 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in HLN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Measured Wealth Private Client Group, LLC holds $841,832 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	13,398	$549,719
2	ELAN	Elanco Animal Health Inc	9,480	$233,302
3	NBIX	Neurocrine Biosciences Inc	140	$23,595
4	HLN	Haleon plc This page	1,997	$18,632
5	VTRS	Viatris Inc	533	$8,464
6	ZTS	Zoetis Inc.	113	$8,120

All Filings in HLN

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,632	1,997	0.0%	Shares	Sole	2026-08-10
2026-03-31	$19,989	1,997	0.0%	Shares	Sole	2026-05-13
2025-12-31	$20,189	1,997	0.0%	Shares	Sole	2026-02-10
2025-09-30	$17,913	1,997	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.